Your browser doesn't support javascript.
loading
DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.
Cunningham, Julie M; Winham, Stacey J; Wang, Chen; Weiglt, Britta; Fu, Zhuxuan; Armasu, Sebastian M; McCauley, Bryan M; Brand, Alison H; Chiew, Yoke-Eng; Elishaev, Esther; Gourley, Charlie; Kennedy, Catherine J; Laslavic, Angela; Lester, Jenny; Piskorz, Anna; Sekowska, Magdalena; Brenton, James D; Churchman, Michael; DeFazio, Anna; Drapkin, Ronny; Elias, Kevin M; Huntsman, David G; Karlan, Beth Y; Köbel, Martin; Konner, Jason; Lawrenson, Kate; Papaemmanuil, Elli; Bolton, Kelly L; Modugno, Francesmary; Goode, Ellen L.
Afiliación
  • Cunningham JM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. cunningham.julie@mayo.edu.
  • Winham SJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • Wang C; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • Weiglt B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Fu Z; Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania.
  • Armasu SM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • McCauley BM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • Brand AH; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
  • Chiew YE; University of Sydney, Sydney, New South Wales, Australia.
  • Elishaev E; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
  • Gourley C; Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
  • Kennedy CJ; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Laslavic A; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Lester J; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
  • Piskorz A; Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
  • Sekowska M; Womens Cancer Research Center, Magee-Womens Research Institute and Hillman Cancer Center, Pittsburgh, Pennsylvania.
  • Brenton JD; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, California.
  • Churchman M; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • DeFazio A; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Drapkin R; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Elias KM; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Huntsman DG; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
  • Karlan BY; University of Sydney, Sydney, New South Wales, Australia.
  • Köbel M; Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
  • Konner J; Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Lawrenson K; Brigham and Women's Hospital, Boston, Massachusetts.
  • Papaemmanuil E; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada.
  • Bolton KL; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Modugno F; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Goode EL; Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
Cancer Epidemiol Biomarkers Prev ; 31(1): 132-141, 2022 01.
Article en En | MEDLINE | ID: mdl-34697060
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Adenocarcinoma de Células Claras / Metilación de ADN Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Adenocarcinoma de Células Claras / Metilación de ADN Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article